Patents by Inventor Eric Persson

Eric Persson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240112550
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical, simulated or virtualized dice and allowing players to physically throw the dice or simulate/virtualize a throw of the dice.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 4, 2024
    Inventors: Eric PERSSON, Kenji ENOKIDO, Hiroki MUNAKATA, Aaron HUANG, Motoya NAKAMURA, Kenji HAMAO
  • Patent number: 11887441
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Grant
    Filed: August 16, 2022
    Date of Patent: January 30, 2024
    Assignee: INTERBLOCK D.O.O.
    Inventors: Eric Persson, Kenji Enokido, Hiroki Munakata, Aaron Huang, Motoya Nakamura, Kenji Hamao
  • Publication number: 20220392314
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Inventors: Eric PERSSON, Kenji ENOKIDO, Hiroki MUNAKATA, Aaron HUANG, Motoya NAKAMURA, Kenji HAMAO
  • Publication number: 20220323538
    Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.
    Type: Application
    Filed: May 31, 2022
    Publication date: October 13, 2022
    Applicant: FERRING INTERNATIONAL CENTER S.A.
    Inventor: Bo-Eric PERSSON
  • Patent number: 11423745
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: August 23, 2022
    Assignee: ARUZE GAMING AMERICA, INC.
    Inventors: Eric Persson, Kenji Enokido, Hiroki Munakata, Aaron Huang, Motoya Nakamura, Kenji Hamao
  • Publication number: 20220218783
    Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.
    Type: Application
    Filed: March 31, 2022
    Publication date: July 14, 2022
    Applicant: FERRING INTERNATIONAL CENTER S.A.
    Inventor: Bo-Eric PERSSON
  • Publication number: 20220218782
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Application
    Filed: March 31, 2022
    Publication date: July 14, 2022
    Applicant: Ferring B.V.
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A. van der Meulen, Jens-Kristian Slott Jensen
  • Publication number: 20220031801
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Application
    Filed: March 12, 2021
    Publication date: February 3, 2022
    Applicant: Ferring B.V.
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A. van der Meulen, Jens-Kristian Slott Jensen
  • Publication number: 20210150862
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Application
    Filed: January 29, 2021
    Publication date: May 20, 2021
    Inventors: Eric PERSSON, Kenji ENOKIDO, Hiroki MUNAKATA, Aaron HUANG, Motoya NAKAMURA, Kenji HAMAO
  • Patent number: 10973870
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: April 13, 2021
    Assignee: Ferring B.V.
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A. van der Meulen, Jens-Kristian Slott Jensen
  • Patent number: 10922927
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: February 16, 2021
    Assignee: ARUZE GAMING (HONG KONG) LIMITED
    Inventors: Eric Persson, Kenji Enokido, Hiroki Munakata, Aaron Huang, Motoya Nakamura, Kenji Hamao
  • Patent number: 10729739
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: August 4, 2020
    Assignee: Ferring B.V.
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A van der Meulen, Jens-Kristian Slott Jensen
  • Publication number: 20200237854
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Application
    Filed: April 17, 2020
    Publication date: July 30, 2020
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A. van der Meulen, Jens-Kristian Slott Jensen
  • Publication number: 20200066106
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Application
    Filed: October 18, 2019
    Publication date: February 27, 2020
    Inventors: Eric PERSSON, Kenji ENOKIDO, Hiroki MUNAKATA, Aaron HUANG, Motoya NAKAMURA, Kenji HAMAO
  • Patent number: 10540853
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: January 21, 2020
    Assignee: Aruze Gaming (Hong Kong) Limited
    Inventors: Eric Persson, Kenji Enokido, Hiroki Munakata, Aaron Huang, Motoya Nakamura, Kenji Hamao
  • Publication number: 20190167755
    Abstract: The invention provides methods and dosing regimens for treating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.
    Type: Application
    Filed: December 18, 2017
    Publication date: June 6, 2019
    Inventor: Bo-Eric PERSSON
  • Publication number: 20180315276
    Abstract: In one aspect, an improved gaming table, such as a craps table, is disclosed herein, which combines electronic displays and wagering interfaces with traditional craps tables having physical dice and allowing players to physically throw the dice.
    Type: Application
    Filed: April 26, 2018
    Publication date: November 1, 2018
    Inventors: Eric PERSSON, Kenji Enokido, Hiroki MUNAKATA, Aaron HUANG, Motoya NAKAMURA, Kenji Hamao
  • Patent number: 9877999
    Abstract: The invention provides methods and dosing regimens for eating metastatic stage prostate cancer in a subject using degarelix, as well as related methods of using degarelix in a subject identified as having metastatic stage prostate cancer, and methods of using degarelix to prevent or delay the progression of locally advanced prostate cancer.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: January 30, 2018
    Assignee: Ferring International Center SA
    Inventor: Bo-Eric Persson
  • Publication number: 20170290879
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Application
    Filed: January 13, 2017
    Publication date: October 12, 2017
    Applicant: Ferring B.V.
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A. van der Meulen, Jens-Kristian Slott Jensen
  • Patent number: 9579359
    Abstract: The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (GnRH) antagonist without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
    Type: Grant
    Filed: December 24, 2013
    Date of Patent: February 28, 2017
    Assignee: FERRING B.V.
    Inventors: Tine Kold Olesen, Bo-Eric Persson, Per Cantor, Egbert A van der Meulen, Jens-Kristian Slott Jensen